You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 16, 2024

CLINICAL TRIALS PROFILE FOR MAXALT-MLT


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for Maxalt-mlt

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00360282 ↗ Does a Migraine Medication Decrease Rotational Motion Sickness in People Suffering From Migraines? Completed Merck Sharp & Dohme Corp. N/A 2006-08-01 The purpose of this study is to determine if Rizatriptan, a migraine medication, lowers motion sickness in migraine sufferers.
NCT00360282 ↗ Does a Migraine Medication Decrease Rotational Motion Sickness in People Suffering From Migraines? Completed University of Pittsburgh N/A 2006-08-01 The purpose of this study is to determine if Rizatriptan, a migraine medication, lowers motion sickness in migraine sufferers.
NCT00397254 ↗ Two Rizatriptan Prescribing Portions for Treatment of Migraine Completed Merck Sharp & Dohme Corp. Phase 4 2006-12-01 The primary objective of this study is to evaluate a clinical limit (CL) of rizatriptan (9 rizatriptan 10mg Orally Disintegrating Tablet (ODT) per month) versus (vs.) a formulary limit (FL) of rizatriptan (27 rizatriptan 10mg ODT per month) as measured by the number of days of migraine per month.
NCT00397254 ↗ Two Rizatriptan Prescribing Portions for Treatment of Migraine Completed Clinvest Phase 4 2006-12-01 The primary objective of this study is to evaluate a clinical limit (CL) of rizatriptan (9 rizatriptan 10mg Orally Disintegrating Tablet (ODT) per month) versus (vs.) a formulary limit (FL) of rizatriptan (27 rizatriptan 10mg ODT per month) as measured by the number of days of migraine per month.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Maxalt-mlt

Condition Name

Condition Name for Maxalt-mlt
Intervention Trials
Migraine 3
Vestibular Migraine 1
Acute Migraine With or Without Aura in Adolescents 1
Chronic Post-traumatic Headache 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Maxalt-mlt
Intervention Trials
Migraine Disorders 8
Headache 3
Motion Sickness 1
Vertigo 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Maxalt-mlt

Trials by Country

Trials by Country for Maxalt-mlt
Location Trials
United States 15
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Maxalt-mlt
Location Trials
California 2
Pennsylvania 2
Michigan 1
Maryland 1
Georgia 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Maxalt-mlt

Clinical Trial Phase

Clinical Trial Phase for Maxalt-mlt
Clinical Trial Phase Trials
Phase 4 2
Phase 3 4
Phase 2/Phase 3 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Maxalt-mlt
Clinical Trial Phase Trials
Completed 8
Withdrawn 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Maxalt-mlt

Sponsor Name

Sponsor Name for Maxalt-mlt
Sponsor Trials
Merck Sharp & Dohme Corp. 7
University of Pittsburgh 1
Clinvest 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Maxalt-mlt
Sponsor Trials
Industry 7
Other 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.